Santa Girl says; Merry Christmas and a Happy Wealthy 2013 for You and Your Family all the best in 2013 from
http://my-big-cash-method.com
Join our winning team - My Big Cash Method Empower Network Join Now.
For many women with frizzy, coarse, unruly hair, there’s no limit to what they would spend—or undergo—to achieve sleek, smooth, straight strands. With the advent of keratin-based salon straightening treatments, women are clamoring for the unprecedented smoothing benefits, spending upwards of $250 to experience the dramatic effects the services promise.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/johnfrieda/47819/
Sleek, innovative and exceptionally efficient: the Saab PhoeniX concept car showcases design features and technologies which will shape the next generation of cars from Saab.
Based on new architecture which will empower the next Saab 9-3 model, the PhoeniX introduces ‘aeromotional’ design: a visual evocation of the aerodynamic design principles and passion for innovation that inspired the creators of Saab’s first car, the iconic Ursaab.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/saab/49582/
Royal Caribbean Cruise owned by Royal Caribbean Cruises Ltd. This is the Norwegian and American cruise line based in Miami, Florida. Royal Caribbean Cruise provides the best facilities and services for visitors and staff.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Elephant seals equipped with antennas on their heads to map the oceans; satellites being used to target mosquitoes; an SMS system preventing the sale of counterfeit medicines in Ghana; smartphones that can predict you’re going to get depressed; credit cards that know two years before you do that you’re headed toward divorce; pills that transmit information directly from your body to your physician.
These and other stories are being told through “The Human Face of Big Data,” the latest groundbreaking, globally crowdsourced initiative from Rick Smolan, the creator of the “Day in the Life” series. The project, made possible through primary sponsorship from EMC® (NYSE:EMC), is based on the premise that the real-time visualization of data collected by satellites, and by billions of sensors, RFID tags, and GPS-enabled cameras and smartphones around the world, is enabling humanity to sense, measure, understand and affect aspects of our existence in ways our ancestors could never have imagined in their wildest dreams.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58095-rick-smolan-human-face-of-big-data-project-globally-crowdsourced
Tektronix, Inc., a leading worldwide provider of test, measurement and monitoring instrumentation, has introduced a new class of affordable spectrum analyzers based on a USB architecture with a list price of just $3,490. The new RSA306 sets a new price/performance threshold for spectrum analyzers and features a broad 9 kHz to 6.2 GHz frequency range, 40 MHz real time bandwidth and weighs in at just 1.2 pounds. When used with Tektronix SignalVu-PC software, it offers advanced analysis capabilities for such applications as budget-conscious research and development, mobile radio network installation, interference hunting and university level lab classes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7074356-tektronix-announces-affordable-full-featured-portable-spectrum-analyzer/
Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, is simplifying the design, fitting and care of full-face masks for sleep apnea patients. With its unique modular design, the new Amara full-face mask further demonstrates Philips’ commitment to developing solutions aimed at improving care and outcomes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57117-philips-respironics-revolutionary-full-face-mask-sleep-therapy
Reply, specialises in the design and implementation of solutions based on new communication channels and digital media, announces Breed Reply (www.breedreply.com), a new Reply advanced incubator for funding, accelerating and supporting the growth and establishment of ideas and start-ups around the Internet of Things (IoT) across Europe and the USA.
Breed Reply has already been active in setting up a growth project with Xmetrics (www.swim-xmetrics.com), a company that offers an innovative device for swimmers. Xmetrics uses sensors, electronic components and software via mobile devices, to enhance the training sessions of professional and amateur swimmers, analysing their main biometric parameters and their real time performance. Breed Reply has signed a "term sheet" for an investment of £675,000 for , 30% of XMetrics.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762565-reply-launches-breed-funding/
